TWST Twist Bioscience Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: TWST

Price (delayed)

$81.14

Market cap

$4.03B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.15

Enterprise value

$3.62B

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights
TWST's gross profit has surged by 80% year-on-year
TWST's revenue is up by 47% YoY and by 4.4% from the previous quarter
Twist Bioscience's equity has surged by 73% YoY but it has decreased by 4.9% QoQ
TWST's gross margin is up by 23% year-on-year but it is down by 3% since the previous quarter
Twist Bioscience's debt has soared by 75% YoY
TWST's quick ratio is down by 20% since the previous quarter and by 9% year-on-year
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.twistbioscience.com/
Peers: NVCR NVAX ONVO ORTX

Key stats

What are the main financial stats of TWST
Market
Shares outstanding
49.63M
Market cap
$4.03B
Enterprise value
$3.62B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
6.89
Price to sales (P/S)
29.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.39
Earnings
Revenue
$132.33M
EBIT
-$153.66M
EBITDA
-$141.67M
Free cash flow
-$139.31M
Per share
EPS
-$3.15
Free cash flow per share
-$2.89
Book value per share
$11.78
Revenue per share
$2.74
TBVPS
$13.71
Balance sheet
Total assets
$702.1M
Total liabilities
$121.28M
Debt
$62.92M
Equity
$580.82M
Working capital
$483.44M
Liquidity
Debt to equity
0.11
Current ratio
8.67
Quick ratio
8.03
Net debt/EBITDA
2.84
Margins
EBITDA margin
-107.1%
Gross margin
39.1%
Net margin
-114.9%
Operating margin
-115.4%
Efficiency
Return on assets
-21.7%
Return on equity
-24.9%
Return on invested capital
-59.8%
Return on capital employed
-24%
Return on sales
-116.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TWST stock price

How has the Twist Bioscience stock price performed over time
Intraday
-10.9%
1 week
-14.58%
1 month
-39.63%
1 year
-33.68%
YTD
-42.57%
QTD
-24.15%

Financial performance

How have Twist Bioscience's revenue and profit performed over time
Revenue
$132.33M
Gross profit
$51.71M
Operating income
-$152.73M
Net income
-$152.1M
Gross margin
39.1%
Net margin
-114.9%
TWST's gross profit has surged by 80% year-on-year
TWST's revenue is up by 47% YoY and by 4.4% from the previous quarter
Twist Bioscience's operating margin has increased by 26% YoY but it has decreased by 7% QoQ
Twist Bioscience's net margin has increased by 26% YoY but it has decreased by 8% from the previous quarter

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation
P/E
N/A
P/B
6.89
P/S
29.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
27.39
TWST's EPS is down by 13% since the previous quarter but it is up by 12% year-on-year
Twist Bioscience's equity has surged by 73% YoY but it has decreased by 4.9% QoQ
TWST's P/B is 30% below its last 4 quarters average of 9.9
TWST's revenue is up by 47% YoY and by 4.4% from the previous quarter
TWST's P/S is 43% below its last 4 quarters average of 52.0

Efficiency

How efficient is Twist Bioscience business performance
The return on equity has surged by 53% year-on-year
The ROA has increased by 49% YoY
TWST's return on sales is up by 25% year-on-year but it is down by 8% since the previous quarter
Twist Bioscience's ROIC has decreased by 24% from the previous quarter but it has increased by 13% YoY

Dividends

What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time
Twist Bioscience's total liabilities has surged by 94% YoY and by 6% QoQ
Twist Bioscience's total assets has surged by 76% YoY but it has decreased by 3.2% QoQ
Twist Bioscience's debt is 89% less than its equity
Twist Bioscience's debt has soared by 75% YoY
Twist Bioscience's equity has surged by 73% YoY but it has decreased by 4.9% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.